Data / Form D filings / Aminex Therapeutics, Inc.
Aminex Therapeutics, Inc.: Form D filings
Aminex Therapeutics, Inc., a biotechnology company in Kenmore, WA, filed 6 Form D notices with the SEC between 2014 and 2025. The latest, on December 5, 2025, reports $15.1 million sold of a $30 million offering to 162 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6830 NE Bothell Way Ste C139, Kenmore, WA, 98028
- Phone
- (425) 286-4222
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1613386
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | New notice | $30,000,030 | $15,084,670 | $14,915,360 | 162 | Oct 25, 2022 | sec.gov |
| Aug 19, 2021 | New notice | $9,141,549 | $6,298,504 | $2,843,045 | 97 | Aug 4, 2021 | sec.gov |
| Aug 14, 2020 | New notice | $3,000,000 | $2,865,125 | $134,875 | 96 | Jul 31, 2020 | sec.gov |
| Jun 1, 2018 | New notice | $14,166,867 | $8,253,117 | $5,913,750 | 96 | May 17, 2018 | sec.gov |
| Nov 12, 2014 | New notice | $2,436,000 | $410,000 | $2,026,000 | 3 | Oct 29, 2014 | sec.gov |
| Jul 11, 2014 | New notice | $1,750,000 | $1,592,697 | $157,303 | 22 | Jun 26, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Deyaa Adib | Director | |
| James Skaggs | Director | |
| Mark Burns | Executive Officer, Director | |
| Jeffrey Miller | Director | |
| David Meeks | Director | |
| Don Dyer | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aminex Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.